Geneos Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $982 | Sell |
27
-131
| -83% | -$4.77K | ﹤0.01% | 2988 |
|
|
2025
Q1 | $5.72K | Buy |
158
+121
| +327% | +$4.38K | ﹤0.01% | 2721 |
|
|
2024
Q4 | $1.56K | Sell |
37
-14
| -27% | -$589 | ﹤0.01% | 2675 |
|
|
2024
Q3 | $2.83K | Buy |
+51
| New | +$2.83K | ﹤0.01% | 2214 |
|
|
2018
Q3 | – | Sell |
-35
| Closed | -$2K | – | 2444 |
|
|
2018
Q2 | $2K | Hold |
35
| – | – | ﹤0.01% | 2127 |
|
|
2018
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 2121 |
|
|
2017
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 2120 |
|
|
2017
Q3 | $1K | Sell |
35
-30
| -46% | -$857 | ﹤0.01% | 2071 |
|
|
2017
Q2 | $4K | Buy |
65
+23
| +55% | +$1.42K | ﹤0.01% | 1806 |
|
|
2017
Q1 | $2K | Sell |
42
-7
| -14% | -$333 | ﹤0.01% | 1918 |
|
|
2016
Q4 | $3K | Buy |
49
+26
| +113% | +$1.59K | ﹤0.01% | 1784 |
|
|
2016
Q3 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 1913 |
|
|
2016
Q2 | – | Sell |
-33
| Closed | -$2K | – | 1837 |
|
|
2016
Q1 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 1682 |
|